Michel BF

References (4)

Title : [Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease] - Ollat_2007_Encephale_33_211
Author(s) : Ollat H , Laurent B , Bakchine S , Michel BF , Touchon J , Dubois B
Ref : Encephale , 33 :211 , 2007
Abstract : Ollat_2007_Encephale_33_211
ESTHER : Ollat_2007_Encephale_33_211
PubMedSearch : Ollat_2007_Encephale_33_211
PubMedID: 17675917

Title : [Pharmacology of Alzheimer's disease: where do we go from here?] - Sellal_2005_Therapie_60_89
Author(s) : Sellal F , Nieoullon A , Michel G , Michel BF , Lacomblez L , Geerts H , Delini-Stula A , Bentue-Ferrer D , Bordet R , Allain H
Ref : Therapie , 60 :89 , 2005
Abstract : Sellal_2005_Therapie_60_89
ESTHER : Sellal_2005_Therapie_60_89
PubMedSearch : Sellal_2005_Therapie_60_89
PubMedID: 15969312

Title : Alzheimer's disease: the pharmacological pathway - Allain_2003_Fundam.Clin.Pharmacol_17_419
Author(s) : Allain H , Bentue-Ferrer D , Tribut O , Gauthier S , Michel BF , Drieu-La Rochelle C
Ref : Fundamental & Clinical Toxicology , 17 :419 , 2003
Abstract : Allain_2003_Fundam.Clin.Pharmacol_17_419
ESTHER : Allain_2003_Fundam.Clin.Pharmacol_17_419
PubMedSearch : Allain_2003_Fundam.Clin.Pharmacol_17_419
PubMedID: 12914543

Title : [Long-term treatment of Alzheimer's disease: followup of a cohort of 255 patients treated with lacrine for four years] - Michel_2001_Rev.Neurol.(Paris)_157_1365
Author(s) : Michel BF , Estadieu MC , Gueriot C , Berthezene P , Allain H , Bongrand MC , Bonnefoy B , Bourrin JC , Chaix L , Graa K , Lejeune A , Messana M , Pras P , Ribiere J , Rihet P , Timon-David P , Tintignac A , Vincent S , Verdier JM , Gastaut JL
Ref : Rev Neurol (Paris) , 157 :1365 , 2001
Abstract : Michel_2001_Rev.Neurol.(Paris)_157_1365
ESTHER : Michel_2001_Rev.Neurol.(Paris)_157_1365
PubMedSearch : Michel_2001_Rev.Neurol.(Paris)_157_1365
PubMedID: 11924005